Companies: 10,795·Total market cap: $144.5T
ChitogenX Inc.

ChitogenX Inc.

CHNXFOTCHealthcare● Active
$0.01
$-0.00(-0.66%)
Market Cap$627628
P/E Ratio
52W High$0.0165
52W Low$0.0011

ChitogenX Inc. (CHNXF) Revenue

Annual & quarterly revenue history · segment & region breakdown

CHNXF · revenue · updated Jun 10, 2026

Core revenue metrics

ChitogenX Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
5 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · ChitogenX Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
CHNXF revenue by year · CHNXF revenue history · CHNXF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income ChitogenX Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

ChitogenX Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from ChitogenX Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

CHNXF revenue · 4 questions

CHNXF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CHNXF revenueCHNXF annual revenuewhat is CHNXF revenueCHNXF TTM revenue

Source: FMP · ChitogenX Inc. SEC filings · GAAP · ChitogenX Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026